Moreover, non-APL leukemia cells were also highly sensitive to atRA treatment in the absence of BM stroma, but became resistant in stromal co-culture conditions; inhibition of CYP26 reversed the stromal-mediated atRA resistance. The gene discussed is CYP26A1; the disease is leukemia.